Literature DB >> 33263777

A Review of Parathyroid Surgery for Primary Hyperparathyroidism from the United Kingdom Registry of Endocrine and Thyroid Surgery (UKRETS).

H Ishii1, M J Stechman2, J C Watkinson3, S Aspinall4, D S Kim5.   

Abstract

BACKGROUND: The United Kingdom Registry of Endocrine and Thyroid Surgeons is a national database holding details on > 28,000 parathyroidectomies.
METHODS: An extract (2004-2017) of the database was analysed to investigate the reported efficacy, safety and use of intra-operative surgical adjuncts in targeted parathyroidectomy (tPTx) and bilateral neck exploration (BNE) for adult, first-time primary hyperparathyroidism (PHPT).
RESULTS: 50.9% of 21,738 cases underwent tPTx. Excellent short-term (median follow-up 35 days) post-operative normocalcaemia rates were reported overall (tPTx 96.6%, BNE 94.5%, p < 0.05) and in image-positive cases (tPTx 96.7%, BNE 96%, p < 0.05). Intra-operative PTH improved overall normocalcaemia rates (tPTx 97.8% vs 96.3%, BNE 95% vs 94.4%: both p < 0.05). Intra-operative nerve monitoring reduced vocal cord (VC) dysfunction in image-positive tPTx, but not in BNE (97.8% vs 93.2%, p < 0.05). Complications were higher following BNE (7.4% vs 3.8%, p < 0.05), especially hypocalcaemia (5.3% vs 2%, p < 0.05). There was no difference in rates of subjective dysphonia following tPTx or BNE (2.4% vs 2.3%, p > 0.05), nor any difference in VC dysfunction when formally examined (4.9% vs 4.1%, p > 0.05).
CONCLUSIONS: In image-positive, first time, adult PHPT cases, tPTx is as safe and effective as BNE, with both achieving excellent short-term results with minimal complications.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33263777      PMCID: PMC7851004          DOI: 10.1007/s00268-020-05885-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  16 in total

1.  Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients.

Authors:  A Bergenfelz; S Jansson; A Kristoffersson; H Mårtensson; E Reihnér; G Wallin; I Lausen
Journal:  Langenbecks Arch Surg       Date:  2008-07-17       Impact factor: 3.445

2.  No need to abandon unilateral parathyroid surgery.

Authors:  Richard Hodin; Peter Angelos; Sally Carty; Herb Chen; Orlo Clark; Gerard Doherty; Quan-Yang Duh; Douglas B Evans; Keith Heller; William Inabnet; Electron Kebebew; Janice Pasieka; Nancy Perrier; Cord Sturgeon
Journal:  J Am Coll Surg       Date:  2012-08       Impact factor: 6.113

Review 3.  Focused Versus Bilateral Parathyroid Exploration for Primary Hyperparathyroidism: A Systematic Review and Meta-analysis.

Authors:  Marcel Jinih; Emer O'Connell; Donal P O'Leary; Aaron Liew; Henry P Redmond
Journal:  Ann Surg Oncol       Date:  2016-11-28       Impact factor: 5.344

4.  The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism.

Authors:  Scott M Wilhelm; Tracy S Wang; Daniel T Ruan; James A Lee; Sylvia L Asa; Quan-Yang Duh; Gerard M Doherty; Miguel F Herrera; Janice L Pasieka; Nancy D Perrier; Shonni J Silverberg; Carmen C Solórzano; Cord Sturgeon; Mitchell E Tublin; Robert Udelsman; Sally E Carty
Journal:  JAMA Surg       Date:  2016-10-01       Impact factor: 14.766

5.  The devil is in the details: Assessing treatment and outcomes of 6,795 patients undergoing remedial parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program.

Authors:  Hadiza S Kazaure; Samantha Thomas; Randall P Scheri; Michael T Stang; Sanziana A Roman; Julie A Sosa
Journal:  Surgery       Date:  2018-10-14       Impact factor: 3.982

6.  The value of intraoperative parathyroid hormone monitoring in localized primary hyperparathyroidism: a cost analysis.

Authors:  Lilah F Morris; Kyle Zanocco; Philip H G Ituarte; Kevin Ro; Quan-Yang Duh; Cord Sturgeon; Michael W Yeh
Journal:  Ann Surg Oncol       Date:  2009-11-03       Impact factor: 5.344

Review 7.  Outcomes of Parathyroidectomy in Patients with Primary Hyperparathyroidism: A Systematic Review and Meta-analysis.

Authors:  Naykky M Singh Ospina; Rene Rodriguez-Gutierrez; Spyridoula Maraka; Ana E Espinosa de Ycaza; Sina Jasim; Ana Castaneda-Guarderas; Michael R Gionfriddo; Alaa Al Nofal; Juan P Brito; Patricia Erwin; Melanie Richards; Robert Wermers; Victor M Montori
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

8.  Clinical practice guideline: improving voice outcomes after thyroid surgery.

Authors:  Sujana S Chandrasekhar; Gregory W Randolph; Michael D Seidman; Richard M Rosenfeld; Peter Angelos; Julie Barkmeier-Kraemer; Michael S Benninger; Joel H Blumin; Gregory Dennis; John Hanks; Megan R Haymart; Richard T Kloos; Brenda Seals; Jerry M Schreibstein; Mack A Thomas; Carolyn Waddington; Barbara Warren; Peter J Robertson
Journal:  Otolaryngol Head Neck Surg       Date:  2013-06       Impact factor: 3.497

Review 9.  Systematic review of cure and recurrence rates following minimally invasive parathyroidectomy.

Authors:  H Ishii; R Mihai; J C Watkinson; D S Kim
Journal:  BJS Open       Date:  2018-05-28

Review 10.  Questionable safety of thyroid surgery with same day discharge.

Authors:  H E Doran; J England; F Palazzo
Journal:  Ann R Coll Surg Engl       Date:  2012-11       Impact factor: 1.891

View more
  2 in total

Review 1.  The role of direct peritoneal resuscitation in the treatment of hemorrhagic shock after trauma and in emergency acute care surgery: a systematic review.

Authors:  Marcelo Augusto Fontenelle Ribeiro-Junior; Cássia Tiemi Kawase Costa; Samara de Souza Augusto; Paola Rezende Néder; Yasmin Garcia Batista Elia; Rishi Rattan; Salomone Di Saverio
Journal:  Eur J Trauma Emerg Surg       Date:  2021-11-13       Impact factor: 3.693

2.  Authors' Reply: A Review of Parathyroid Surgery for Primary Hyperparathyroidism from the United Kingdom Registry of Endocrine and Thyroid Surgery.

Authors:  Hiro Ishii; Michael Stechman; John Watkinson; Sebastian Aspinall; Dae Kim
Journal:  World J Surg       Date:  2021-06-24       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.